Legend Capital’s Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China – QNT Press Release5 years ago
Pathr.ai™ Announces Integration with Hanwha Techwin America to Bring Spatial Intelligence Technology to the Security Industry – QNT Press Release5 years ago
